Key points are not available for this paper at this time.
A large percentage of oncology clinical trials do not achieve minimum projected accruals. Trial development time appears to be one important predictor of the likelihood of successfully achieving the minimum accrual goals.
Cheng et al. (Wed,) studied this question.